(Q34075406)

30 July 2017

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer (English)

1 reference

30 July 2017

0 references

1 reference

corrigendum / erratum

0 references

7

Robin Farias-Eisner

1 reference

30 July 2017

Sanaz Memarzadeh

1

1 reference

30 July 2017

Katherine R Kozak

2

1 reference

30 July 2017

Lisbeth Chang

3

1 reference

30 July 2017

Sathima Natarajan

4

1 reference

30 July 2017

Peter Shintaku

5

1 reference

30 July 2017

Srinivasa T Reddy

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

18 July 2002

1 reference

Proceedings of the National Academy of Sciences of the United States of America

30 July 2017

1 reference

30 July 2017

99

1 reference

30 July 2017

10647-10652

1 reference

30 July 2017

16

1 reference

Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

5 July 2018

Cancer statistics, 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

The urokinase receptor is required for human monocyte chemotaxis in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Oligomerization of p53 is necessary to inhibit its transcriptional transactivation property at high protein concentration.

5 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.152127499

Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.152127499

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.152127499

Expression of the urokinase plasminogen activator receptor is transiently required during "priming" of PC12 cells in nerve growth factor-directed cellular differentiation.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=125001

Microsatellite instability and somatic mutations in endometrial carcinomas

28 October 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.152127499

Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.152127499

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.152127499

Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis

21 January 2018

1 reference

12 December 2020

Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium

1 reference

12 December 2020

ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients

1 reference

12 December 2020

The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.152127499

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference